跳至主要内容
临床试验/CTRI/2024/06/069270
CTRI/2024/06/069270尚未招募3 期

A study to evaluate the clinical effectiveness of multigenetic pharmacogenomics guided treatment in drug naive schizophrenics in northern Indian population an open label randomized controlled trial - nil

Dr Amrita Kumari Pandey0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.ICD-10 or 11 criteria for schizophrenia
  • 2.Positive and Negative Syndrome Scale (PANSS) more than 60 score
  • 3.Patient or legally authorized representative willing to give informed consent
  • 4.Two generations of the patient living in northern India
  • 5.Schizophrenic patients who have not received any psychotropics

排除标准

  • 1.Concurrent substance use disorders
  • 2.Neurological conditions
  • 3.Other comorbid axis I psychiatric diagnoses
  • 4.Severe unstable organic illnesses
  • 5.Not able to give consent
  • 6.Pregnant or lactating females

研究者

发起方
Dr Amrita Kumari Pandey

相似试验